About eEAS
Instructions
Access eEAS
Features
References
Our tools
Our partners
English
Deutsch

Home

What is the eEAS?

The Erlangen Atopy Score (Erlangen Atopie Score; EAS) was developed by Diepgen and colleagues in 1991 to determine atopic skin diathesis, i.e. the tendency of the skin to develop atopic eczema. This is a major risk factor for the occurrence of occupational skin diseases. The score is a systematically developed listing of anamnestic and clinical features to objectify the likelihood of atopic skin diathesis and the associated risk of eczema. The EAS was developed for, and should only be completed by, healthcare professionals. On DermaValue you will now find the electronic version of the EAS (eEAS).

Validation of questionnaire

paper version: yes digital version: no

How to use the eEAS

The Erlanger Atopy Score consists of 24 criteria divided into 6 domains: atopic family history, atopic self-anamnesis, atopic minimal forms, atopic stigmata, dermal neurovegetative and laboratory values. Each feature is scored based on relevance to atopic skin diathesis with a score of 0 - 3. The total score can range from 0 - 42.

Starting at 10 points, atopic skin diathesis is likely to be present, and the probability increases further at 15 and 20 points. The eEAS should only be completed by healthcare professionals.

When is the EAS used?

Persons with an atopic skin diathesis are exposed to an increased risk of developing hand eczema during occupational wet work (e.g. gardeners, cooks, geriatric nurses). The EAS can be used to detect these persons at an early stage, inform them about the risk, and recommend a retraining or a different choice of occupation. The use of the EAS is explicitly recommended in the "Bamberger Empfehlung - Empfehlung zur Begutachtung von arbeitsbedingten Hauterkrankungen und Hautkrebserkrankungen", of the German Social Accident Insurance.